Amanda Borges de Oliveira, Alisson Pugliesi, R. Xavier, L. Mota, M. Bértolo, M. González-Gay, G. Citera, Luiz Sérgio F. de Carvalho
{"title":"比较利妥昔单抗、阿巴接受和托珠单抗对甲氨蝶呤或抗肿瘤坏死因子难治的类风湿关节炎患者的疗效:系统评价和网络","authors":"Amanda Borges de Oliveira, Alisson Pugliesi, R. Xavier, L. Mota, M. Bértolo, M. González-Gay, G. Citera, Luiz Sérgio F. de Carvalho","doi":"10.47660/cbr.2021.1990","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":424002,"journal":{"name":"SBR 2021 Congresso Brasileiro de Reumatologia","volume":"1 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"1900-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Compared efficacy of rituximab, abatacept, and tocilizumab in patients with rheumatoid arthritis refractory to methotrexate or anti-TNF agents: a systematic review and network\",\"authors\":\"Amanda Borges de Oliveira, Alisson Pugliesi, R. Xavier, L. Mota, M. Bértolo, M. González-Gay, G. Citera, Luiz Sérgio F. de Carvalho\",\"doi\":\"10.47660/cbr.2021.1990\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"\",\"PeriodicalId\":424002,\"journal\":{\"name\":\"SBR 2021 Congresso Brasileiro de Reumatologia\",\"volume\":\"1 1\",\"pages\":\"0\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"1900-01-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"SBR 2021 Congresso Brasileiro de Reumatologia\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.47660/cbr.2021.1990\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"SBR 2021 Congresso Brasileiro de Reumatologia","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.47660/cbr.2021.1990","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
Compared efficacy of rituximab, abatacept, and tocilizumab in patients with rheumatoid arthritis refractory to methotrexate or anti-TNF agents: a systematic review and network